| scholarly article | Q13442814 |
| P2093 | author name string | Yamaoka K | |
| Ito K | |||
| Nakamura H | |||
| Ito H | |||
| Takeda N | |||
| Sakai T | |||
| Honda M | |||
| Seino Y | |||
| Hattori S | |||
| Takekoshi Y | |||
| Nakagawa K | |||
| Awazu M | |||
| Koitabashi Y | |||
| Yoshikawa N | |||
| Matsuyama S | |||
| Iitaka K | |||
| Ninomiya M | |||
| P433 | issue | 1 | |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 101-109 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group | |
| P478 | volume | 10 |
| Q24800133 | A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616] |
| Q44675538 | A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy |
| Q34557198 | Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy |
| Q73385385 | Acute glomerulonephritis |
| Q34455482 | Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy |
| Q43961791 | Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy |
| Q46486599 | Can azathioprine and steroids alter the progression of severe Henoch-Schönlein nephritis in children? |
| Q39809045 | Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy. |
| Q87393387 | Chapter 10: Immunoglobulin A nephropathy |
| Q46788440 | Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study |
| Q89482795 | Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT |
| Q47338195 | Comparison of long-term follow-up outcomes between multiple-drugs combination therapy and tonsillectomy pulse therapy for pediatric IgA nephropathy |
| Q92908883 | Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials |
| Q44045291 | Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria |
| Q80167715 | Efficacy of tonsillectomy pulse therapy versus multiple-drug therapy for IgA nephropathy |
| Q84978295 | Evidence-based practice guideline for the treatment of CKD |
| Q88840186 | Favorable renal outcome in Japanese children with ANCA-associated pauci-immune glomerulonephritis: impact of urine screening program |
| Q24672961 | Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis |
| Q87683417 | Henoch-Schönlein purpura nephritis |
| Q46846514 | Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide |
| Q33731499 | Idiopathic immunoglobulin A nephropathy in children and adolescents |
| Q57100792 | IgA Nephropathy: A European Perspective in the Corticosteroid Treatment |
| Q48316624 | IgA nephropathy with presentation of nephrotic syndrome at onset in children |
| Q80588162 | IgA nephropathy: what's new? |
| Q55509866 | Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features. |
| Q90254423 | Immunosuppressive agents for treating IgA nephropathy |
| Q36585452 | Improved renal survival in Japanese children with IgA nephropathy |
| Q47946442 | Incidence of pediatric IgA nephropathy |
| Q39178756 | Inflammation in IgA nephropathy. |
| Q88008525 | Initial treatment with pulse methylprednisolone followed by short-term prednisolone and tonsillectomy for childhood IgA nephropathy |
| Q46715751 | Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphamide therapy |
| Q52956831 | Long-term morbidity of IgA nephropathy in children evaluated with newly proposed remission criteria in Japan. |
| Q35030576 | Long-term results of a randomized controlled trial in childhood IgA nephropathy |
| Q37467985 | Nationwide survey on current treatments for IgA nephropathy in Japan |
| Q47853398 | Presentation of pediatric Henoch-Schönlein purpura nephritis changes with age and renal histology depends on biopsy timing |
| Q35957866 | Proteinuria during Follow-Up Period and Long-Term Renal Survival of Childhood IgA Nephropathy |
| Q41834049 | Proteinuria rebound in IgA nephropathy associated with obesity-related glomerulopathy |
| Q43043426 | Resolution of Henoch-Schönlein purpura nephritis after acquired IgA deficiency. |
| Q53667381 | Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy. |
| Q41998646 | Successful therapy with tonsillectomy plus pulse therapy for the relapse of pediatric IgA nephropathy treated with multi-drugs combination therapy |
| Q37090470 | The improvement of renal survival with steroid pulse therapy in IgA nephropathy |
| Q89724873 | Treatment of IgA nephropathy in children: a land without KDIGO guidance |
| Q38689787 | Treatment of IgA nephropathy with renal insufficiency |
| Q46309050 | Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience |
| Q83119157 | Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity |
| Q50740539 | Usefulness of an automated urinary flow cytometer in mass screening for nephritis. |
| Q82771811 | Validity of the Oxford classification of IgA nephropathy in children |
Search more.